Ameritas Investment Partners’s Lunai Bioworks LNAI Stock Holding History

Ameritas Investment Partners’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-151	Closed	-$6.57K	–	3318
2025 Q1	$6.57K	Hold	151	–	–	﹤0.01%	2918
2024 Q4	$10.1K	Buy	151 +91	+152%	+$6.04K	﹤0.01%	2900
2024 Q3	$2.31K	Hold	60	–	–	﹤0.01%	3093
2024 Q2	$8.36K	Buy	+60	New	+$8.18K	﹤0.01%	2976
2023 Q2	–	Sell	-19	Closed	-$1.36K	–	3192
2023 Q1	$1.36K	Hold	19	–	–	﹤0.01%	2973
2022 Q4	$1.85K	Hold	19	–	–	﹤0.01%	3012
2022 Q3	$2K	Hold	19	–	–	﹤0.01%	3010
2022 Q2	$2K	Buy	+19	New	+$8.69K	﹤0.01%	3034
2021 Q2	–	Sell	-4	Closed	-$1K	–	3201
2021 Q1	$1K	Hold	4	–	–	﹤0.01%	3089
2020 Q4	$1K	Hold	4	–	–	﹤0.01%	3063
2020 Q3	$1K	Hold	4	–	–	﹤0.01%	3086
2020 Q2	$1K	Hold	4	–	–	﹤0.01%	3052
2020 Q1	$1K	Hold	4	–	–	﹤0.01%	3005
2019 Q4	$2K	Hold	4	–	–	﹤0.01%	2979
2019 Q3	$2K	Hold	4	–	–	﹤0.01%	3032
2019 Q2	$2K	Buy	+4	New	+$1.95K	﹤0.01%	3025

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Ameritas Investment Partners's LNAI Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 151 shares — an estimated $6.57K sold.

Ameritas Investment Partners first reported a position in LNAI in Q2 2019 and held it in 16 quarters. The position peaked at $10.1K in Q4 2024. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

Ameritas Investment Partners reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 151 Lunai Bioworks shares in Q2 2025, an estimated $6.57K.
Ameritas Investment Partners first reported a position in Lunai Bioworks in Q2 2019 and held it in 16 quarters.
Ameritas Investment Partners's Lunai Bioworks position peaked at $10.1K in Q4 2024.
42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.